Suchergebnisse - "1389-2010" OR "1873-4316"

PubPharm (6.272)

6261

Inhibition of cellular proliferation by drug targeting of cyclin-dependent kinases

enthalten in: Current pharmaceutical biotechnology | 2000

von Pérez-Roger, I. | Ivorra, C. | Díez, A. | +4

6262

Use of recombinant human erythropoietin as an antianemic and performance enhancing drug

enthalten in: Current pharmaceutical biotechnology | 2000

von Jelkmann, W.

6263

Growth velocity, final height and bone mineral metabolism of short children treated long term with growth hormone

enthalten in: Current pharmaceutical biotechnology | 2000

von Lanes, R.

6264

Transcription factors as potential targets for therapeutic drugs

enthalten in: Current pharmaceutical biotechnology | 2000

von Latchman, D.

6265

Modulation of metabolism through transcriptional control has created new treatment opportunities for type 2 diabetes

enthalten in: Current pharmaceutical biotechnology | 2000

von Boel, E. | Albrektsen, T. | Fleckner, J. | +1

6266

Advances in biotechnology for tissue engineering of bone

enthalten in: Current pharmaceutical biotechnology | 2000

von Ripamonti, U. | Tasker, J.

6267

The chick embryo chorioallantoic membrane as a model for in vivo research on anti-angiogenesis

enthalten in: Current pharmaceutical biotechnology | 2000

von Ribatti, D. | Vacca, A. | Roncali, L. | +1

6268

Toward the rational design of cell fate modifiers : notch signaling as a target for novel biopharmaceuticals

enthalten in: Current pharmaceutical biotechnology | 2000

von Zlobin, A. | Jang, M. | Miele, L.

6269

Current pharmaceutical biotechnology : the international journal for timely in-depth reviews in pharmaceutical biotechnology

Erschienen: Hilversum, Bentham Science Publ., 2000-

6270

Current pharmaceutical biotechnology

Erschienen: Hilversum, Bentham Science Publ., 2000-